Fellowship · Aurora, CO
Sponsored by University of Colorado School of Medicine
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Autophagy · 2021 · 2,291 citations · Jean Levy
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 213 citations · Christine McMahon
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Nature medicine · 2025 · 207 citations · Mathew Angelos
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
The New England journal of medicine · 2025 · 187 citations · Maureen O'Brien
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet (London, England) · 2022 · 698 citations · Manali Kamdar
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Science (New York, N.Y.) · 2021 · 792 citations ·
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.
Blood · 2023 · 369 citations · Manali Kamdar
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Nature medicine · 2021 · 534 citations · Everett Meyer, Terry Fry